Us Bancorp \De\ Forma Therapeutics Holdings, Inc. Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$7.12 - $20.24 $23,887 - $67,905	3,355 Added 1863.89%	3,535 $71,000
Q2 2022 Aug 01, 2022	SELL	$5.1 - $10.0 $21,221 - $41,610	-4,161 Reduced 95.85%	180 $1,000
Q1 2022 May 11, 2022	BUY	$8.34 - $14.69 $26,738 - $47,096	3,206 Added 282.47%	4,341 $40,000
Q4 2021 Feb 11, 2022	BUY	$13.6 - $24.89 $1,849 - $3,385	136 Added 13.61%	1,135 $16,000
Q3 2021 Nov 10, 2021	BUY	$21.22 - $25.7 $21,198 - $25,674	999 New	999 $23,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.